Cargando…
Ever closer to a prophylactic vaccine for HCV
INTRODUCTION: With 3 – 4 million new infections occurring annually, hepatitis C virus (HCV) is a major global health problem. There is increasing evidence to suggest that HCV will be highly amenable to a vaccine approach, and despite advances in treatment, a vaccine remains the most cost-effective a...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Informa UK, Ltd.
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3741017/ https://www.ncbi.nlm.nih.gov/pubmed/23651228 http://dx.doi.org/10.1517/14712598.2013.791277 |